FdaApplication

NDA 050715

Back to search

Identifiers

Properties

PropertyValue
applicant_nameNOVARTIS PHARMACEUTICALS CORP
application_typeNDA
approval_date1995-07-14

Products (3)

ProductActive ingredientStrengthDosage form
NEORALCYCLOSPORINE25MGCAPSULE;ORAL
NEORALCYCLOSPORINE100MGCAPSULE;ORAL
NEORALCYCLOSPORINE50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE;ORAL

3 products